Академический Документы
Профессиональный Документы
Культура Документы
9 Therapeutics Development
10 Pipeline Products for Traumatic Brain Injury - Overview
10 Pipeline Products for Traumatic Brain Injury - Comparative Analysis
11 Traumatic Brain Injury - Therapeutics under Development by Companies
12 Traumatic Brain Injury - Therapeutics under Investigation by Universities/Institutes
17 Traumatic Brain Injury - Pipeline Products Glance 18 Late Stage Products
18 Clinical Stage Products
19 Early Stage Products
20 Unknown Stage Products
21 Traumatic Brain Injury - Products under Development by Companies
22 Traumatic Brain Injury - Products under Investigation by Universities/Institutes
27 Traumatic Brain Injury - Companies Involved in Therapeutics Development
28 Adamas Pharmaceuticals, Inc.
28 ALSP, Inc.
29 Amarantus Bioscience Holdings, Inc.
30 Athersys, Inc.
31 BHR Pharma, LLC
32 Cognosci, Inc.
33 Euroscreen S.A.
34 Grupo Ferrer Internacional, S.A.
35 International Stem Cell Corporation 36 Io Therapeutics, Inc.
37 Ischemix
38 Karyopharm Therapeutics, Inc.
39 Kyorin Pharmaceutical Co., Ltd.
40 Levolta Pharmaceuticals, Inc.
41 Lixte Biotechnology Holdings, Inc.
42 Lpath, Inc. 43 MandalMed, Inc.
44 Mapreg S.A.S.
45 Mnemosyne Pharmaceuticals, Inc.
46 Neuralstem, Inc.
47 Neuren Pharmaceuticals Limited 48 NeuroHealing Pharmaceuticals Inc.
49 NeuroNascent, Inc.
50 Neuronax SAS
51 NeuroVive Pharmaceutical AB
52 Omeros Corporation
53 PharmatrophiX, Inc.
54 Phylogica Limited
55 Prevacus, Inc.
56 PsychoGenics, Inc.
57 QR Pharma, Inc.
58 RAPID Pharmaceuticals AG
59 RegeneRx Biopharmaceuticals, Inc.
60 Remedy Pharmaceuticals, Inc.
61 Sage Therapeutics 62 SanBio, Inc.
63 STATegics, Inc.
64 Tetra Discovery Partners LLC
65 VG Life Sciences, Inc.
66 Traumatic Brain Injury - Therapeutics Assessment
67 Assessment by Monotherapy Products
67 Assessment by Combination Products
68 Assessment by Target 69 Assessment by Mechanism of Action
72 Assessment by Route of Administration
75 Assessment by Molecule Type
77 Drug Profiles 79 2-DG - Drug Profile
79 ALP-496 - Drug Profile 81 amantadine hydrochloride ER - Drug Profile
83 AMRS-001 - Drug Profile
85 apomorphine hydrochloride - Drug Profile
88 AST-002 - Drug Profile
90 AVL-8168 - Drug Profile
91 Cell Therapy to Activate hNT-3 for Spinal Cord and Traumatic Brain Injury - Drug Profile
92 CHEC-7 - Drug Profile 94 CHEC-9 - Drug Profile
95 CMX-2043 - Drug Profile 97 CNB-001 - Drug Profile
99 COG-1410 - Drug Profile
101 cyclosporine - Drug Profile
103 dexamethasone acetate + melatonin - Drug Profile
107 EPO-Variant - Drug Profile
s Disease - Drug
171 Small Molecules for Stroke and Traumatic Brain Injury - Drug Profile
172 Small Molecules to Activate P2Y Receptor for Stroke and Traumatic Brain Injury - Drug Profile
173 Small Molecules to Agonize TrkB for Ophthalmology and Central Nervous System - Drug Profile
174 Small Molecules to Antagonize NMDA2A for Central Nervous System Disorders - Drug Profile
175 Small Molecules to Antagonize TLR-4 for CNS Disorders - Drug Profile
176 Small Molecules to Inhibit PBR for Traumatic Brain Injury and Neurodegenerative Diseases - Drug Profile
177 Stem Cell Therapy for CNS Disorders - Drug Profile
178 STSE-15 - Drug Profile
179 T-094 - Drug Profile
180 TBI-121 - Drug Profile
181 TBI-122 - Drug Profile
182 TBI-123 - Drug Profile
183 trofinetide - Drug Profile
184 UH-0113 - Drug Profile
186 UH-0213 - Drug Profile
187 VG-1177 - Drug Profile
188 VitalHeme - Drug Profile
190 VOLT-02 - Drug Profile
192 Traumatic Brain Injury - Recent Pipeline Updates
193 Traumatic Brain Injury - Dormant Projects
250 Traumatic Brain Injury - Discontinued Products
Contact Us:
iData Insights
Tel: 1-866-237-2965
Web: http://www.idatainsights.com
Email: info@idatainsights.com